Alibaba Health Information Technology Limited Stock
Equities
241
BMG0171K1018
Drug Retailers
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.590 HKD | +0.56% |
|
-1.10% | -28.91% |
| 05-26 | Alibaba Health is Winning Battles but Losing the War |  |
| 05-20 | Jefferies Adjusts Alibaba Health Information Technology's Price Target to HK$5.30 from HK$6, Keeps at Buy | MT |
| Capitalization | 50.17B 58.03B 7.41B 6.41B 5.89B 5.54B 10.31B 706B 10.47B 69.96B 27.23B 341B 27.81B 27.21B 1,187B | P/E ratio 2026 |
34.3x | P/E ratio 2027 * | 24.3x |
|---|---|---|---|---|---|
| Enterprise value | 39.12B 45.25B 5.78B 5B 4.59B 4.32B 8.04B 550B 8.17B 54.55B 21.23B 266B 21.69B 21.21B 926B | EV / Sales 2026 |
1.65x | EV / Sales 2027 * | 0.99x |
| Free-Float |
36.47% | Yield 2026 |
1.45% | Yield 2027 * | 0.93% |
| 1 day | +0.56% | ||
| 1 week | -1.10% | ||
| Current month | -1.10% | ||
| 1 month | -19.14% | ||
| 3 months | -30.02% | ||
| 6 months | -34.01% | ||
| Current year | -28.91% |
| 1 week | 3.52 |  | 3.88 |
| 1 month | 3.52 | | 4.67 |
| Current year | 3.52 | | 7.91 |
| 1 year | 3.52 | | 7.91 |
| 3 years | 2.59 | | 7.91 |
| 5 years | 2.59 | | 18.68 |
| 10 years | 2.59 | | 30.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 47 | 28/11/2023 |
Meng Yue Sheng
DFI | Director of Finance/CFO | 44 | 15/05/2026 |
Hua Zhang
HRO | Human Resources Officer | - | 01/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CHM | Chairman | 47 | 15/12/2025 |
Yi Fei Huang
BRD | Director/Board Member | 53 | 09/06/2019 |
Jiaojiao Huang
BRD | Director/Board Member | 44 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/25 | Other | Chief Financial Officer | 453,600 | 0.0028% | ||
| 13/06/25 | Other | Chief Executive Officer | 2,381,400 | 0.0148% | ||
| 18/06/24 | Other | Chief Executive Officer | 164,883 | 0.0010% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | -1.10% | -20.22% | -26.13% | 7.41B | |
| +1.01% | -1.30% | -4.29% | -22.57% | 15.53B | |
| +0.35% | +0.99% | -19.49% | -12.59% | 5.63B | |
| +1.02% | -5.87% | -24.33% | -30.60% | 3.56B | |
| -0.67% | -2.69% | -20.03% | -45.19% | 3.34B | |
| -0.08% | +0.21% | -38.11% | -5.59% | 3.33B | |
| -0.93% | -3.45% | -7.81% | -41.00% | 2.68B | |
| -0.63% | -2.20% | -20.27% | -6.11% | 2.57B | |
| -0.78% | +4.49% | +96.03% | - | 2.56B | |
| +0.68% | -6.43% | -0.09% | +41.83% | 1.7B | |
| Average | +0.05% | -1.42% | -5.86% | -16.44% | 4.83B | |
| Weighted average by Cap. | +0.37% | -1.23% | -8.98% | -20.72% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 35.16B 40.67B 5.19B 4.5B 4.12B 3.88B 7.23B 495B 7.34B 49.03B 19.08B 239B 19.49B 19.07B 832B | 38.7B 44.77B 5.71B 4.95B 4.54B 4.27B 7.96B 544B 8.08B 53.96B 21B 263B 21.45B 20.99B 916B |
| Net income | 2.21B 2.56B 327M 283M 260M 244M 455M 31.12B 462M 3.08B 1.2B 15.05B 1.23B 1.2B 52.34B | 2.14B 2.47B 316M 273M 251M 236M 439M 30.07B 446M 2.98B 1.16B 14.54B 1.18B 1.16B 50.57B |
| Net Debt | -11.05B -12.78B -1.63B -1.41B -1.3B -1.22B -2.27B -155B -2.31B -15.41B -6B -75.17B -6.12B -5.99B -261B | -12.01B -13.9B -1.77B -1.54B -1.41B -1.33B -2.47B -169B -2.51B -16.75B -6.52B -81.73B -6.66B -6.51B -284B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/06/26 | 3.590 $ | +0.56% | 79,486,110 |
| 04/06/26 | 3.570 $ | -2.46% | 149,198,800 |
| 03/06/26 | 3.660 $ | -4.19% | 141,310,900 |
| 02/06/26 | 3.820 $ | +2.14% | 138,022,700 |
| 01/06/26 | 3.740 $ | +3.03% | 149,857,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 241 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition